• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Purple Biotech Ltd. - American Depositary Shares (NQ:PPBT)

4.870 +0.800 (+19.66%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Purple Biotech Ltd. - American Depositary Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform
March 25, 2026
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Purple Biotech Regains Compliance with Nasdaq
March 17, 2026
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Purple Biotech Announces CEO Transition
March 13, 2026
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Purple Biotech Announces Plan to Implement ADS Ratio Change
February 25, 2026
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Purple Biotech Achieves Toxicology Milestone Demonstrating an Expanded Therapeutic Window for CAPTN-3 Platform Tri-specific Antibody, IM1240
January 07, 2026
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
December 16, 2025
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
Purple Biotech Reports Positive New Preclinical Data Demonstrating Multi-Arm Anti-Tumor Activity Across Two CAPTN-3 Tri-Specific Antibodies at ESMO Immuno-Oncology Congress 2025
December 11, 2025
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress
December 04, 2025
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Purple Biotech Reports Third Quarter 2025 Financial Results and Provides Business Update
November 14, 2025
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
What's going on in today's after hours session ↗
November 07, 2025
The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
November 07, 2025
 
Via Benzinga
News headline image
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
October 30, 2025
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
October 30, 2025
 
Via Benzinga
News headline image
Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗
October 30, 2025
 
Via Benzinga
News headline image
Curious about the most active stocks on Wednesday? ↗
October 29, 2025
Wednesday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity! 
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Wednesday's session. ↗
October 29, 2025
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
October 29, 2025
 
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
October 29, 2025
The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
News headline image
Dow Surges 250 Points; Verizon Posts Mixed Q3 Results ↗
October 29, 2025
 
Via Benzinga
Topics Stocks
News headline image
Purple Biotech Shares Soar 92% On Breakthrough For Experimental Cancer Drug ↗
October 29, 2025
Purple said that it has achieved a commercially viable yield for IM1240, positioning the program competitively for future development. 
Via Stocktwits
News headline image
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
October 29, 2025
Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
October 29, 2025
 
Via Benzinga
News headline image
Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform
October 29, 2025
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification
October 20, 2025
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Purple Biotech Receives Intention to Grant a European Patent Covering NT219 Combinations with Immunotherapies or MEK Inhibitors to Overcome Tumor Resistance
September 10, 2025
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants
September 05, 2025
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
September 05, 2025
 
Via Benzinga
News headline image
Unusual volume stocks in Friday's session ↗
September 05, 2025
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume. 
Via Chartmill
News headline image
Friday's session: top gainers and losers ↗
September 05, 2025
Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
September 04, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap